Talk Track 1 - Regulatory Science (RS) track
Future-Ready Regulatory Frameworks: Adapting to Global Change
Wed, Nov 18, 2026 · 11:30 AM–1:00 PM IST Main Auditorium, CIDCO Auditorium & Convention Centre
About this session
Session Overview : This session can bring together topics on evolving regulatory requirements such as U.S. NDC/barcoding changes, EU MDR transition, and global public standards for biologics. The focus would be on how regulators and industry are preparing for and adapting to rapidly changing global frameworks. Programme: RS.S1.T1: Are You Ready for the Changes to the U.S. National Drug Code and Barcode Requirements?; RS.S1.T2: Navigating the EU MDR Transition Extension: Regulatory Strategy, Risk-Based Planning, and Compliance Execution; RS.S1.T3: What Next in Global Public Standards to Foster Biologics Development?; RS.S1.T4: Panel Discussion: What does a truly future-ready regulatory framework look like?.
Speakers
-
Vice President Regulatory Affairs · Intas Pharmaceuticals
Chair
-
Sr Director and Head-Biologics · US Pharmacopeia
Speaker
-
Director-Regulatory Affairs and Pharmacovigilance · Eli Lilly and Company (India) Pvt. Ltd.
Speaker
-
Joint Drugs Controller (India) · Central Drugs Standard Control Organization (CDSCO), Government of India
Speaker
-
Head of International Regulatory Policy and Innovation, Executive Director · Takeda
Speaker
